Revvity Inc (RVTY)
114.53
-1.52
(-1.31%)
USD |
NYSE |
Nov 15, 09:57
Revvity Cash and Short Term Investments (Quarterly): 1.230B for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.230B |
| June 30, 2024 | 1.954B |
| March 31, 2024 | 1.695B |
| December 31, 2023 | 1.603B |
| September 30, 2023 | 1.430B |
| June 30, 2023 | 2.071B |
| March 31, 2023 | 2.461B |
| December 31, 2022 | 454.36M |
| September 30, 2022 | 400.74M |
| June 30, 2022 | 360.86M |
| March 31, 2022 | 669.76M |
| December 31, 2021 | 603.32M |
| September 30, 2021 | 487.37M |
| June 30, 2021 | 572.81M |
| March 31, 2021 | 988.23M |
| December 31, 2020 | 402.04M |
| September 30, 2020 | 258.29M |
| June 30, 2020 | 218.54M |
| March 31, 2020 | 195.15M |
| December 31, 2019 | 191.88M |
| September 30, 2019 | 392.97M |
| June 30, 2019 | 150.02M |
| March 31, 2019 | 134.25M |
| December 31, 2018 | 163.11M |
| September 30, 2018 | 149.51M |
| Date | Value |
|---|---|
| June 30, 2018 | 163.39M |
| March 31, 2018 | 180.80M |
| December 31, 2017 | 202.13M |
| September 30, 2017 | 709.49M |
| June 30, 2017 | 616.31M |
| March 31, 2017 | 288.33M |
| December 31, 2016 | 359.26M |
| September 30, 2016 | 311.66M |
| June 30, 2016 | 248.08M |
| March 31, 2016 | 210.73M |
| December 31, 2015 | 237.93M |
| September 30, 2015 | 195.07M |
| June 30, 2015 | 192.17M |
| March 31, 2015 | 168.92M |
| December 31, 2014 | 174.82M |
| September 30, 2014 | 203.68M |
| June 30, 2014 | 205.26M |
| March 31, 2014 | 224.11M |
| December 31, 2013 | 173.24M |
| September 30, 2013 | 132.30M |
| June 30, 2013 | 112.47M |
| March 31, 2013 | 125.87M |
| December 31, 2012 | 171.44M |
| September 30, 2012 | 170.83M |
| June 30, 2012 | 171.40M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
191.88M
Minimum
Dec 2019
2.461B
Maximum
Mar 2023
912.38M
Average
588.06M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Bionano Genomics Inc | 18.94M |
| Avantor Inc | 285.30M |
| Bruker Corp | 148.10M |
| Azenta Inc | 595.84M |
| Harvard Bioscience Inc | 4.569M |